Robotic Brachytherapy and Sublobar Resection for T1 Non-Small Cell Lung Cancer in High-Risk Patients

被引:6
作者
Blasberg, Justin D. [1 ]
Belsley, Scott J.
Schwartz, Gary S.
Evans, Andrew
Wernick, Iddo
Ashton, Robert C., Jr.
Bhora, Faiz Y.
Connery, Cliff P.
机构
[1] Columbia Univ Coll Phys & Surg, St Lukes Roosevelt Hosp Ctr, Dept Surg, New York, NY 10023 USA
关键词
THORACOSCOPIC WEDGE RESECTION; LIMITED RESECTION; I-125; BRACHYTHERAPY; LOBECTOMY; SEGMENTECTOMY; CARCINOMA; PULMONARY; SURVIVAL; IMPLANTATION;
D O I
10.1016/j.athoracsur.2009.09.052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Sublobar lung resection and brachytherapy seed placement is gaining acceptance for T1 non-small cell lung cancer (NSCLC) in select patients with comorbidities precluding lobectomy. Our institution first reported utilization of the da Vinci system for robotic brachytherapy developed experimentally in swine and applied to high-risk patients 5 years ago. We now report seed dosimetrics and midterm follow-up. Methods. Eleven high-risk patients with stage IA NSCLC who were not candidates for conventional lobectomy underwent limited resection of 12 primary tumors. To reduce locoregional recurrence, I-125 brachytherapy seeds were robotically sutured intracorporeally over resection margins to deliver 14,400 cGy 1 cm from the implant plane. Patients were followed with dosimetric computed tomography scans at 30 +/- 16 days. Survival and sites of recurrence were documented. Results. Resected tumor size averaged 1.48 +/- 0.38 cm (range, 1.1 to 2.1 cm). Perioperative mortality was 0% and recurrence was 9% (1 of 11 [margin recurrence at 6 months with resultant mortality at 1 year]). Follow-up duration was 31.82 +/- 17.35 months. Dosimetrics confirmed 14,400 cGy delivery using 24.21 +/- 4.6 I-125 seeds (range, 17 to 30 seeds) over a planning target volume of 10.29 +/- 2.39 cc(3). Overall, 84.1% of the planning target volume was covered by 100% of the prescription dose (V100), and 88.2% was covered by 87% of the prescription dose (V87), comparable to open dosimetric data at our institution. Follow-up imaging confirmed seed stability in all patients. Conclusions. Robotic I-125 brachytherapy seed placement is a feasible adjuvant procedure to reduce the incidence of recurrence after sublobar resection in medically compromised patients. Tailored robotic seed placement delivers an exact dosing regimen in a minimally invasive fashion with equivalent precision to open surgery. (Ann Thorac Surg 2010;89:360-7) (C) 2010 by The Society of Thoracic Surgeons
引用
收藏
页码:360 / 367
页数:8
相关论文
共 35 条
[1]  
[Anonymous], 116 NCRP
[2]   Sublobar resection with brachytherapy versus lobectomy for stage Ib nonsmall cell lung cancer [J].
Birdas, TJ ;
Koehler, RPM ;
Colonias, A ;
Trombetta, M ;
Maley, RH ;
Landreneau, RJ ;
Keenan, RJ .
ANNALS OF THORACIC SURGERY, 2006, 81 (02) :434-439
[3]  
Campione A, 2004, J CARDIOVASC SURG, V45, P67
[4]   Factors predicting poor survival after resection of stage IA non-small cell lung cancer [J].
Chang, Michael Y. ;
Mentzer, Steven J. ;
Colson, Yolonda L. ;
Linden, Philip A. ;
Jaklitsch, Michael T. ;
Lipsitz, Stuart R. ;
Sugarbaker, David J. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2007, 134 (04) :850-856
[5]   Intraoperative 125I brachytherapy for high-risk stage I non-small cell lung carcinoma [J].
Chen, A ;
Galloway, M ;
Landreneau, R ;
d'Amato, T ;
Colonias, A ;
Karlovits, S ;
Quinn, A ;
Santucci, T ;
Kalnicki, S ;
Brown, D .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 44 (05) :1057-1063
[6]  
Coloni G F, 1983, Ital J Surg Sci, V13, P49
[7]   Intraoperative brachytherapy following thoracoscopic wedge resection of stage I lung cancer [J].
d'Amato, T ;
Galloway, M ;
Szydlowski, G ;
Chen, A ;
Landreneau, RJ .
CHEST, 1998, 114 (04) :1112-1115
[8]   New therapeutic approaches for early stage non-small cell lung cancer [J].
El-Sherif, A ;
Luketich, JD ;
Landreneau, RJ ;
Fernando, HC .
SURGICAL ONCOLOGY-OXFORD, 2005, 14 (01) :27-32
[9]   Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: A 13-year analysis [J].
El-Sherif, Amgad ;
Gooding, William E. ;
Santos, Ricardo ;
Pettiford, Brian ;
Ferson, Peter F. ;
Fernando, Hiran C. ;
Urda, Susan J. ;
Luketich, James D. ;
Landreneau, Rodney J. .
ANNALS OF THORACIC SURGERY, 2006, 82 (02) :408-416
[10]   Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer [J].
Fernando, HC ;
Santos, RS ;
Benfield, JR ;
Grannis, FW ;
Keenan, RJ ;
Luketich, JD ;
Close, JM ;
Landreneau, RJ .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2005, 129 (02) :261-267